South Wales, Sept. 17 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "QAMNURV" on Aug. 22. The details about the trademark application no. UK00004253158 published in the journal no. 2025/036 (Sept. 5).
Glaxo Group Limited filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceutical and medicinal preparations and substances; vaccines.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004253158
Disclaimer: Curated by HT Syndication.
